Clinical trials: CPPD - Calcium Pyrophosphate Deposition Disease
Calcium Pyrophosphate Deposition Disease
Effect of Probenecid on Synovial Fluid ATP Levels in CPPD
This study will investigate the hypothesis that probenecid, a medication currently used for gout, reduces levels of ATP in the joint fluid of patients with calcium pyrophosphate deposition disease (CPPD), another common type of…
- Trial name
- NCT02243631
- Testing
- Probenecid
- Where
- United States
- Volunteers
- 8 people
- Sponsor
- VA Office of Research and Development